CooperCompanies retains CooperSurgical and expands buyback for CooperCompanies stock
Published on 10/03/2026 at 11:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 9, 2026, CooperCompanies announced that its board had concluded to retain CooperSurgical and expanded the share repurchase authorization from $2 billion to $3 billion, according to the CooperCompanies release published by GlobeNewswire.
At 11:48 a.m. CEST on October 3, 2026, Lang & Schwarz showed CooperCompanies stock at EUR 50.57 in weekend trading, with a change of plus 0.00 percent versus the EUR 50.57 close at Lang & Schwarz on October 2, 2026.
Weekend trading
The bid was EUR 50.42 and the ask was EUR 50.72 at the quoted time. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of CooperCompanies stock.
Strategic review and results
CooperCompanies said its strategic review evaluated portfolio options, capital allocation, strategic alternatives, corporate structure, leadership, operations and strategy. The board said continued ownership of CooperSurgical was preferable to pursuing a transaction at that time. The same release said the company had repurchased $445 million of shares during the fiscal year and would continue to focus on CooperVision innovation and growth initiatives. These details were reported in the GlobeNewswire release.
Third-quarter results
In a separate September 9, 2026 release, CooperCompanies reported fiscal third-quarter revenue of $1.066 billion for the period ended July 31, 2026, up 1 percent year over year. GAAP diluted earnings per share were $2.24, while non-GAAP diluted earnings per share were $1.15. The company also reported free cash flow of $273.0 million and $339.1 million in share repurchases for the quarter, according to its earnings release.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
